Cereno Scientific AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was SEK 5.8 million compared to SEK 10.95 million a year ago. Revenue was SEK 5.8 million compared to SEK 10.95 million a year ago. Net loss was SEK 11.08 million compared to SEK 7.25 million a year ago.
For the nine months, sales was SEK 31.86 million compared to SEK 36.56 million a year ago. Revenue was SEK 31.86 million compared to SEK 36.56 million a year ago. Net loss was SEK 26.17 million compared to SEK 19.01 million a year ago.